Skip to main navigation
Intellia Therapeutics home page
  • Home
  • About
    • Who We Are
    • Core Values
    • Leadership
    • Partners
  • Our Science
    • What is CRISPR?
    • CRISPR Videos
    • Scientific Publications & Presentations
    • Glossary
  • Programs & Pipeline
  • Patient Focus
    • Disease Focus
    • Patient Stories
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Presentation
    • Events
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
  • Contact
menu
Intellia Therapeutics Head office building

SEC Filing
Details

investor relations

  • Overview
  • Press Releases
  • Scientific Publications & Presentations
  • Corporate Presentation
  • Events
  • Press Kit
  • Corporate Governance
  • Financial Info
  • Analyst Coverage
  • Investor Resources

Document Details

Form
10-K
Filing Date
Mar 14, 2018
Document Date
Dec 31, 2017
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

Quick
Links

RSS FEEDS
EMAIL ALERTS
PRINT PAGE

Footer Legal

  • Cookie Policy
  • Terms of Use
  • Privacy Policy
© 2026. Intellia Therapeutics, Inc.

Intellia Therapeutics and the Intellia Therapeutics logo are registred trademarks with the U.S. Patent & Trademark Offce.